Q32 Bio Inc. (QTTB)
NASDAQ: QTTB
· Real-Time Price · USD
1.98
0.10 (5.32%)
At close: Aug 15, 2025, 3:59 PM
1.99
0.41%
After-hours: Aug 15, 2025, 07:01 PM EDT
Q32 Bio Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.33M | -11.03M | -14.19M | -17.59M | -16.98M | 1.03M | -16.12M | -32.95M | -35.04M | -28.84M | -34.3M | -33.73M | -29.09M | 92.11M | -33.58M | -30.61M | -30.5M | -1.07M |
Depreciation & Amortization | -23K | 48K | 120K | 123K | 121K | 123K | n/a | 136K | 564K | 587K | 633K | 635K | 786K | 545K | 2.4M | 2.4M | 2.39M | 2.36M |
Stock-Based Compensation | 1.36M | 1.34M | 1.25M | 1.38M | 1.34M | 417K | n/a | 300K | 310K | 296K | 318K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 757K | n/a | -757K | -2.05M | -4.28M | n/a | -6.97M | -1.28M | 3.51M | -4.56M | 6.74M | 3.78M | -854K | -4.47M | -2.9M | 460K | -1.82M | -35.06M |
Other Non-Cash Items | -5.74M | n/a | 416K | -153K | 63K | 170K | 10.66M | 606K | 8.92M | 2.96M | 8.38M | 4.37M | 12.01M | -133.18M | 11.17M | 11.39M | 8.42M | 4.05M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -974K | n/a | 974K | -3.28M | -6.76M | -576K | -11.54M | 3.13M | 3.27M | -2.07M | 3.04M | 3.99M | -6.92M | 3.23M | -4.26M | -1.65M | -727K | -35.16M |
Operating Cash Flow | -11.71M | -12.48M | -11.43M | -19.52M | -22.21M | -14.55M | -21.57M | -24.94M | -23.66M | -26.05M | -27.2M | -24.93M | -30.85M | -30.68M | -30.43M | -25.39M | -24.11M | -29.82M |
Capital Expenditures | 2K | n/a | -2K | -58K | -15K | n/a | n/a | -1K | 1K | -228K | -9K | -6K | -121K | -1.15M | -338K | -477K | -764K | -817K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 216K | 338K | n/a | n/a | n/a | n/a | n/a | 130M | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -47.96M | 1K | -25.28M | n/a | -108.21M | -49.25M | n/a | -1K | 1K | -12.97M | -84.42M |
Sales Maturities Of Investments | n/a | n/a | n/a | 10M | 9.9M | 97K | 31.5M | 24.86M | 61M | 56.88M | 18M | n/a | 8M | 39.46M | 44M | 5M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 2K | n/a | -2K | 9.94M | 9.89M | 97K | 31.72M | -22.76M | 61M | 31.37M | 17.99M | -108.22M | -41.37M | 168.31M | 43.66M | 4.52M | -13.74M | -85.23M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -317K | n/a | 317K | 997K | -5.52M | 50.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -317K | n/a | 317K | 997K | -5.52M | 99.35M | 14K | 18K | 2K | 150K | 32K | 124K | n/a | 440K | 1K | 379K | 49.75M | 2.04M |
Net Cash Flow | -23.13M | -12.48M | -11.11M | -8.58M | -17.85M | 84.89M | 10.15M | -47.69M | 37.34M | 5.47M | -9.18M | -133.03M | -71.94M | 139.75M | 12.55M | -20.48M | 11.9M | n/a |
Free Cash Flow | -11.7M | -12.48M | -11.43M | -19.58M | -22.23M | -14.55M | -21.57M | -24.94M | -23.66M | -26.28M | -27.21M | -24.94M | -30.97M | -31.83M | -30.77M | -25.86M | -24.88M | -30.64M |